BRITISH COLUMBIA, Canada--(BUSINESS WIRE)--InNexus Biotechnology Inc. (OTCBB:IXSBF)(TSX:IXS), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL™) technology, announces today that it will host an open house and scientific technology demonstration at its state-of-the-art research and development facilities located on the campus of Mayo Clinic in Scottsdale, AZ on September 28, 2007 from Noon to 4:00pm.
